In a decisive step to improve access to medicines in the developing world, the Executive Board of UNITAID, the international health financing agency, has given the green light for a patent pool for HIV/AIDS medicines to open for business.

“Although these are early days, the patent pool could become a mechanism that systematically offers licenses to generic manufacturers, reducing prices and facilitating the combination of drugs from different makers into fixed-dose or one pill combinations,” said Dr. Tido von Schoen-Angerer, Executive Director of Médecins Sans Frontières’ (MSF) Campaign for Access to Essential Medicines.

The UNITAID board has decided to set up and fund the licensing agency that will run the pool. Once established, formal negotiations with drug companies can begin.

“This is an important decision, but the pool will be judged on its outcome for patients,” said Michelle Childs, Director of Policy & Advocacy at MSF. “We’ve been encouraged by the positive responses from a number of companies to our campaign in support of the pool.  Now that the pool has been given a green light, patent holders need to move from expressions of general support to firm and formal license commitments.  We urge them to do so.  This needs to happen fast, as the clock is ticking for millions of patients.

“The Board has confirmed that this pool is for all developing countries, but as this is a voluntary mechanism, the ultimate outcome will depend on the decisions of patent holders.  Countries can still use the legal mechanisms at their disposal such as compulsory licensing and pro-health patent laws to ensure people have access to the life-saving medicines they need,” said Childs.

Related News:

 India: Court gives boost to access to medicines, latest appeal by Bayer rejected - 09.02.2010 16:11

 Geneva: Key countries at risk of exclusion from UNITAID Patent Pool - 08.12.2009 11:00

 MSF calls on drug companies to pool HIV patents - 01.10.2009 16:43

 HIV/AIDS treatment: Optimize now, or pay more later… - 20.07.2009 12:16